Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TNNI3K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101927610 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
EPS8L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA3F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CABLES2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB16-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP2A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC79160 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPSB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANHX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SON - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on